EffiKIR trial of lirilumab in elderly patients with AML does not meet primary efficacy endpoint Feb. 6, 2017
Fortress Biotech's Mustang Bio closes private placement financing to support immunotherapy pipeline Feb. 3, 2017
Targovax reports survival data from first cohort of phase I/II study of TG-01 in pancreatic cancer Feb. 2, 2017
RSS